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SObjectives: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is becoming the
preferred method of mediastinal staging for lung cancer. We investigated the learning curve for EBUS-TBNA
using risk-adjusted cumulative sum (Cusum).
Methods: A retrospective study of EBUS-TBNA was performed at a single academic institution for patients
with mediastinal or hilar lymphadenopathy in the setting of proven or suspected lung cancer. A sampling
pass was defined as a full retraction and repositioning of the aspiration needle. Rapid on-site evaluation was
not available. To track proficiency, risk-adjusted Cusum analysis was performed using acceptable and unaccept-
able failure rates of 10% and 20%, respectively. Failure was defined as false negative or nondiagnostic results.
Results: During the study period, 231 patients underwent EBUS-TBNA. Prevalence of mediastinal or hilar ma-
lignancy was 66.7% (154 out of 231). Sensitivity was 92.2% (142 out of 154), and negative predictive value was
87.9% (58 out of 66). Node size was identified as a significant predictor of EBUS-TBNA success by multiple
regression. Risk-adjusted Cusum analysis demonstrated that the first and only unacceptable decision interval
was crossed at 22 cases. Individual practitioner learning curves were highly variable, and the operator with
the highest volume was the most consistently proficient.
Conclusions: In our experience, attainment of an acceptable failure rate for EBUS-TBNA required 22 cases.
Node size is a predictor of EBUS-TBNA success. Risk-adjusted Cusum proved a powerful evaluative tool to
monitor the training process of this new procedure. (J Thorac Cardiovasc Surg 2013;146:1387-92)Supplemental material is available online.
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Accurate mediastinal staging of patients with lung cancer is
critical for therapeutic decision making and prognosis.1 In
most surgical series, pathologic staging with mediastino-
scopy has been the gold standard in preoperative evaluation
of mediastinal lymphadenopathy, with large clinical studies
demonstrating good sensitivity and lowmorbidity.2 Howev-
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The Journal of Thoracic and Cargeneral anesthesia, its invasive nature, potential for compli-
cations, and the inability to evaluate hilar and inferior medi-
astinal node stations. When applied to patients with
suspected lung cancer and radiographic evidence of medias-
tinal lymphadenopathy, the accuracy of endobronchial
ultrasound-guided transbronchial needle aspiration
(EBUS-TBNA) is comparable to mediastinoscopy with an
expected sensitivity of 90% or greater.3,4 When used in
conjunction with endoscopic ultrasound, it also allows the
pathologic staging of almost all mediastinal node stations.
Enthusiasm for the EBUS-TBNA procedure has driven
many physicians to incorporate this staging modality into
their practices. Unfortunately, theHalstedian apprenticeship
model is not feasible for the majority of established practi-
tioners who desire training in EBUS-TBNA, and there are
no current requirements mandating bronchoscopic training
before application in patients.5 To develop and maintain
proficiency with EBUS-TBNA, an evaluative tool is neces-
sary that can measure proficiency during the training period
and beyond. Cumulative sum (Cusum) is one such tool that
compares real-world performance to a predetermined defi-
nition of proficiency. In medical training, Cusum has suc-
cessfully been applied to procedures such as placement of
epidural catheters, sentinel lymph node biopsy, and thoraco-
scopic thymectomy.6-8 Here, we describe the application of
Cusum analysis to evaluate the learning curve for
EBUS-TBNA. Our objective is to establish the merits ofdiovascular Surgery c Volume 146, Number 6 1387
Abbreviations and Acronyms
CUSUM ¼ cumulative sum
EBUS-TBNA ¼ endobronchial ultrasound-guided
transbronchial needle aspiration
ROSE ¼ rapid on-site pathologic evaluation
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SCusum analysis for the purpose of monitoring the adoption
of EBUS-TBNA at institutional and individual levels.METHODS
All patients with known or suspected lung cancer undergoing EBUS-
TBNA for tissue diagnosis or staging between January 2007 and October
2010 at the Washington University in St Louis School of Medicine, St
Louis, Mo, were prospectively entered into a database. Tissue diagnosis
procedures are defined as those for patients with radiologic evidence of un-
resectable malignant disease who received EBUS-TBNA to obtain tissue
for pathologic diagnosis. Staging procedures are those performed for pa-
tients with potentially resectable disease. Preceding chart review, data
collection, and analysis, the full study protocol underwent approval by
the Institutional Review Board of the Washington University in St Louis
School of Medicine. Patient demographics, clinical and radiologic staging
information, EBUS-TBNA details, subsequent procedure details, pathol-
ogy results, and clinical outcomes were retrospectively obtained via elec-
tronic chart review. A total of 254 patients were reviewed. Patients
receiving a negative or nondiagnostic EBUS-TBNA who failed to
follow-up with additional tissue sampling or radiographic surveillance
were excluded (23 out of 254; 9.1%), for a final study cohort of 231.Within
the study group of 231 patients, mean age was 62.5 years, and 118 out of
231 participants (51%) were men (Table 1).
A positive EBUS-TBNA was defined as pathology results consistent
with malignancy or benign nodal disease; that is, histoplasmosis, sarcoid-
osis, or necrotizing granuloma. A negative result was defined as normal
lymphoid findings or reactive lymphadenopathy. A procedure was consid-
ered nondiagnostic if it failed to produce adequate sampling, or if the sam-
ple yielded indeterminate results. Negative or nondiagnostic results from
EBUS-TBNAwere followed by mediastinoscopy or surgical resection, or
were followed by repeat computed tomography imaging at an interval of
6 months to evaluate for mediastinal node progression. All EBUS-TBNA
cytology samples diagnostic of malignancy or benign disease were
assumed to be true positives. False negatives were defined as cases of non-
diagnostic or negative EBUS-TBNA in which the final surgical node stage
was N1 or greater, or cases in which the patient had evidence of mediastinal
disease progression on follow-up imaging.
All cases of EBUS-TBNA considered for this study were performed by
thoracic surgeons under general anesthesia using a linear endobronchial ul-
trasound scope. None of the participant surgeons had prior EBUS-TBNA
experience before the study period, and no participant received formal
training for the procedure. Rapid on-site pathologic evaluation (ROSE)
of biopsy specimens was not routinely performed. Selective EBUS-
TBNA sampling was guided by preoperative radiographic staging.Medias-
tinal lymph nodes subject to sampling by EBUS-TBNA included those>1
cm on preoperative imaging or during endobronchial ultrasound. A single
aspiration, or ‘‘pass,’’ of a lymph node was defined as any number of sam-
pling oscillations with the biopsy needle along a single axis.
Cusum analysis for depiction of learning progression is described in
detail elsewhere by Bolsin and Colson.9 Briefly, a classic Cusum analysis
evokes trainer-defined parameters to measure a trainee’s proficiency at an
assigned task, and iterates this measurement for subsequent repetitions.
Measurement of proficiency is based on a binary outcome for each1388 The Journal of Thoracic and Cardiovascular Surperformance of a given task (success vs failure). The trainer determines
a priori acceptable and unacceptable failure rates (p0 and p1, respectively),
which derive a numeric decrement (s) representing each success and incre-
ment (1-s) representing each failure, based on the following calculation:
s ¼ ln½ð1p0Þ=ð1p1Þ=flnðp1=p0Þ þ ln½ð1p0Þ=ð1p1Þg
Graphic depiction of Cusum of all deflections depicts the classic
learning curve. By defining type 1 and type 2 error rates, the trainer derives
acceptability/unacceptability boundaries that demarcate when a trainee has
crossed into proficiency or inadequacy. A type 1 error (a) is the wrongful
accusation of inadequacy, whereas a type 2 error (b) is the wrongful certi-
fication of proficiency. For ease of graphic interpretation, acceptable a and
b are set to be equal. The acceptability/unacceptability boundary spacing
(h0) is then determined by the following calculation:
h0 ¼ ln½ð1aÞ=b=flnðp1=p0Þ þ ln½ð1p0Þ=ð1p1Þg
Thus, a Cusum curve that trends upward and crosses a series of unac-
ceptability lines depicts a trainee who is inadequate, whereas a curve that
trends downward ormaintains within the bounds of 2 acceptability lines de-
picts a trainee who is proficient (Figure 1).
Cusum calculation adjustments for risk are discussed thoroughly by
Steiner and colleagues.10 Case-specific risk factors are identified through
multiple regression and used to modify the increments and decrements
associated with failure and success, respectively. For example, for patient
t with risk of failure qt, when the odds ratio of failure for proficiency is
set to R0 and odds ratio of failure for inadequacy is set to R1, the deflections
become modified to the following:
ln½ð1qtþR0qtÞ=ð1qtþR1qtÞ success
lnf½ð1qtþR0qtÞR1=½ð1qtþR1qtÞR0g failure
For the purposes of our study, a successful EBUS-TBNAwas defined as
a true positive or a true negative procedure result. A failed EBUS-TBNA
was defined as a nondiagnostic or false negative result. Values for accept-
able and unacceptable failure rates as well as type 1 and type 2 error rates
were determined by expert consensus within our institution and from liter-
ature review. Because all nondiagnostic or negative EBUS-TBNA’s receive
pathologic verification or subsequent follow-up, the risks of a failed proce-
dure are mild. The linear EBUS provides a view of mediastinal anatomy
foreign to most new practitioners, and the procedure was considered mod-
erate in difficulty. Given that literature consensus on sensitivity of EBUS-
TBNA is roughly 90%,11 an acceptable failure rate was defined as p0¼ 0.1,
whereas an unacceptable rate was defined as p1 ¼ 0.2. Type 1 and type 2
errors were set to be equivalent at a ¼ b ¼ 0.1. Cusum curves were gener-
ated for our institution as a whole and for individual surgeons who per-
formed a minimum of 20 cases during the study period. Risk-adjusted
Cusumwas calculated on an institution level based on significant predictors
of procedure success as determined by multiple logistic regression of
contributing factors node size, tissue-sampling versus staging cohort, and
number of nodes sampled. The primary outcomes of our study were
numbers of cases necessary to attain proficiency on an institution level
based on unadjusted and risk-adjusted Cusum analyses. Secondary out-
comes included Cusum results of individual practitioners and significant
predictors of procedural success by logistic multiple regression.RESULTS
EBUS-TBNA was performed for tissue diagnostic pur-
poses for 114 patients (49.4%), and for staging for all
others. Distribution of disease included lung cancer, meta-
static disease, lymphoma, and benign disorders such as
sarcoidosis, histoplasmosis, and necrotizing granuloma.gery c December 2013
TABLE 1. Demographics and disease prevalence
Variable Result
Patient demographic
Total, n 231
Age, y 62.7  12.6
Women 113 (48.9)
Disease prevalence
Non–small cell lung cancer 132 (57.1)
Small cell lung cancer 31 (13.4)
Metastasis 27 (11.7)
Lymphoma 8 (3.5)
Benign* 32 (13.9)
Values are presented as mean  standard deviation or n (%). *Benign diseases
include sarcoidosis, fungal infection, and necrotizing granuloma.
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was 66.7% (154 out of 231). EBUS-TBNA yielded
adequate sampling for pathologic diagnosis in 90% (201
out of 231) of cases, with an overall sensitivity of 92.2%
(142 out of 154), accuracy of 86.6% (200 out of 231) and
negative predictive value of 87.9% (58 out of 66).
To determine the relationship between EBUS-TBNA
sensitivity and thoroughness of node sampling, procedures
were categorized based on the number of passes performed
per node and number of node stations sampled per proce-
dure. An average of 3.36 passes were made to each node
sampled. Sensitivity of EBUS-TBNA did not improve
further among cases involving>3 passes per node. Sensi-
tivity was highest at 94.1% (48 out of 51) when lymph no-
des were sampled with three passes, and lowest at 90.7%
(39 out of 43) among procedures for which the number of
passes was not recorded. Average number of node stations
sampled per procedure was 1.51, and was not significantly
different between the staging and tissue-diagnosis cohorts
(1.50 vs 1.51, respectively). Sensitivity of EBUS-TNBNA
was not significantly correlated with number of node sta-
tions sampled.
Cumulative observed sensitivity of EBUS-TBNA was
compared with an expected sensitivity of 90%
(Figure E1). After an initial period of high volatility due
to low volume, cumulative sensitivity approximatedFIGURE 1. Example risk-adjusted cumulative sum (Cusum) graphs. Positive d
attempts.Horizontal lines demarcate unacceptable and acceptable thresholds. Fr
of training, and a learner reverting to inadequacy after a period of proficiency.
The Journal of Thoracic and Carexpected levels beyond 90 cases. Unadjusted Cusum anal-
ysis was performed implementing an acceptable failure
rate of 0.1, an unacceptable failure rate of 0.2, and equiv-
alent type 1 and type 2 error rates of 0.1. At an institution
level, the first and only unacceptable threshold was
crossed at 32 cases, indicating maintenance of a proficient
level of practice beyond this case number. Logistical
regression using predictors node size, number of nodes
sampled, and staging versus tissue diagnosis cohort re-
vealed that only node size was a significant predictor of
procedure success (P ¼ .044). Under risk-adjusted Cusum
analysis accounting for node size, the first and only unac-
ceptable threshold was crossed at 22 cases, indicating pro-
ficiency thereafter (Figure 2). All procedures were
performed by thoracic surgery faculty with or without
the assistance of thoracic fellows. Five practitioners per-
formed an average of 45 cases, with case volume ranging
from 7 to 116 at the time of analysis. Cusum analyses for
individuals were performed for the three busiest operators
at our institution. Comparison of Cusum curves of individ-
ual surgeons demonstrated variability in the rate of
acquiring proficiency (Figure 3).
DISCUSSION
Current guidelines for surgical training are often set
with the assumption that repetition leads to proficiency.
Rather than using objective measures of ability, trainees
are considered proficient after a target number of at-
tempts. However, learning curves among trainees differ
greatly; a recent survey of graduating pulmonary fellows
revealed that 50% believed that their trans-bronchial nee-
dle aspiration training was inadequate.12 Although the
American College of Chest Physicians recommends per-
forming 50 radial EBUS procedures to attain a level of
proficiency,13 this number may underestimate or overesti-
mate the actual volume necessary among many trainees,14
and does not address differences between radial and linear
EBUS. Intermittent testing using standardized assessment
tools such as the Bronchoscopy Skills and Tasks Assess-
ment Tool have demonstrated good internal and externaleflections indicate failed attempts, negative deflections indicate successful
om left to right, graphs depict a subpar performer, a performer in the process
diovascular Surgery c Volume 146, Number 6 1389
FIGURE 2. Institutional risk-adjusted cumulative sum (Cusum). Left, Unadjusted Cusum shows that an unacceptable threshold (red lines) was crossed at
32 cases (indicated by *), and only acceptable thresholds (gray lines) are crossed in subsequent cases, indicating proficient performance beyond 32 cases.
Right, Risk-adjusted Cusum shows an unacceptable threshold crossed at 22 cases (indicated by *) with subsequent proficiency.
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success in a clinical setting.
To our knowledge, our study is the first to apply risk-
adjusted Cusum analysis to a department-wide adoption of
EBUS-TBNA using strict radiographic staging criteria for
sampling and without the assistance of ROSE. Our findings
suggest that risk-adjusted Cusum analysis may be used to
track acquisition of proficiency with EBUS-TBNA as an
institution, which in our series occurred after 22 cases. This
result stands in contrast to a comparison of expected andFIGURE 3. Individual risk-adjusted cumulative sum (Cusum) curves. A
B, Operator 2 crosses an unacceptable threshold at 27 cases, and then maintains
after 22 cases.
1390 The Journal of Thoracic and Cardiovascular Surobserved cumulative sensitivity. Cumulative sensitivity is
demonstrably inferior to Cusum for tracking training prog-
ress given its inability to incorporate risk-modification and
reflect point-in-time performance. Predictive factors for suc-
cess of EBUS-TBNA included the size of lymph nodes
sampled. Individual practitioners’ learning curveswerehigh-
ly variablewithin our institution, andhighlighted the need for
continuation of outcomes-basedmeasures of quality. Neither
number of passes per lymphnode nor number of lymphnodes
sampled was associated with EBUS-TBNA success., Operator 1 demonstrated proficiency throughout the study period.
proficiency thereafter. C, Operator 3 has yet to be demonstrate proficiency
gery c December 2013
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STo date, several studies have attempted to describe the
learning curve of EBUS-TBNA in real-world settings.
Tracking of proficiency surrogates such as sensitivity and
diagnostic rate in a clinical setting may produce a graphi-
cally meaningful learning curve. However, these measures
fall short when attempting to delineate a threshold of profi-
ciency, because any statistical comparison of serial mea-
sures of yield requires division of patients into arbitrary
temporal cohorts.16 It is encouraging, nevertheless, that a
recent study by Abu-Hijleh and colleagues17 tracking serial
EBUS-TBNA diagnostic yield over cohorts of 25 patients
found a jump in sensitivity following the first 25 to 50 cases.
This lends external validity to the results of our Cusum
analysis.
During the past 20 years, Cusum has been applied in the
surgical field to detect small deviations from expected out-
comes for established, high-risk procedures.18 Over time,
as investigators grew savvy to the inability of classic Cu-
sum to address case variability and patient risk factors,
more sophisticated, risk-adjusted Cusum methodologies
were developed and extensively studied.19-22 Although
Cusum analysis for medical procedures has been used
with success in several fields, its application to
bronchoscopy is sparse. On an individual level, mastery
of EBUS-TBNA is a complex and highly variable pro-
cess.23 A multicenter retrospective study by Kemp and col-
leagues24 applied unadjusted Cusum to several individual
practitioners at different institutions with variable criteria
for node sampling and elucidated significant differences
in learning curves. This is in keeping with the unsettling
variability among trainees when relating volume to profi-
ciency. Thus far, no individual surgeon has required re-
training once proficiency was obtained. Looking forward,
we anticipate that continued monitoring of individual per-
formance with Cusum analyses after every 20 cases will
promote quality assurance. One weakness of classic, unad-
justed Cusum is its inability to account for case variability
in its assessment of performance. By incorporating risk
adjustment for variables predictive of success, Cusum be-
comes a more powerful and valid evaluative tool.25
Within our series, adjusting for node size in Cusum calcu-
lations allowed amendment of our institutional time-to-
proficiency.
Studying the learning curve of an entire department has
several merits. First, the installment of a new biopsy tech-
nique depends not only on the proficiency of physicians,
but also the support staff in the operating room, surgical pa-
thologists, and the hospital infrastructure. Second,
modeling the learning curve of a department accounts for
assistance and teaching between colleagues. Last,
institution-wide application of Cusum allows identification
of the need for infrastructure retraining and protocol adjust-
ments in addition to individual retraining. For example, de-
viation across multiple unacceptability thresholds mayThe Journal of Thoracic and Carprompt a quality investigation that elucidates the need for
adoption of ROSE.
Our experience with EBUS-TBNA thus far does not
include the routine use of ROSE. Aspirated samples are
subjectively studied by a cytotechnologist before submis-
sion for cytology and pathology. In our experience, lymph
node sampling with >3 passes was not associated with
increased sensitivity or negative predictive value. This is
in concordance with the study by Abu-Hijleh and col-
leagues17 showing no increase in diagnostic yield for cases
necessitating>3 aspirations per node. We did find a signif-
icant correlation between node size and EBUS-TBNA suc-
cess, and this may be due to relative ease of the procedure
and higher disease prevalence.
Our study is not without limitations. First, as a retro-
spective, single-institution study, there are inherent limita-
tions when attempting to apply our results to influence
technical protocols at other institutions. For example, the
number of passes and node stations necessary to procure
sufficient tissue could be affected by the availability of
ROSE, which we did not employ. Second, the guidelines
followed by study participants for mediastinal sampling
were equivalent to ‘‘selective sampling’’ as defined by
Detterbeck and colleagues,26 and it is possible that
employment of ‘‘complete sampling’’ or ‘‘systematic sam-
pling’’ protocols could alter the expected success rate—
and thus the learning curve—of EBUS-TBNA. However,
differences in technical protocol would not affect the
applicability of Cusum as a learning assessment tool at
most centers. Additionally, our risk-adjusted Cusum anal-
ysis accommodated for node size as the sole predictive
variable in relation to procedure success. With higher vol-
ume for analysis, it is possible that additional risk factors
may be elucidated through multiple regression. Lastly, our
results pertain to the experience of a high-volume aca-
demic center with multiple collaborative practitioners of
EBUS-TBNA. Thus, our institution-level results may not
be applicable to a smaller practice with fewer opportu-
nities for collaboration. Because the establishment of a
high-quality EBUS-TBNA service is clearly a multidisci-
plinary effort, the learning curve for an institution adopt-
ing this technique will also vary based on the ancillary
resources available.
CONCLUSIONS
EBUS-TBNA is an accurate evaluative tool for medias-
tinal adenopathy with advantages of decreased morbidity
and wider lymph node accessibility over mediastinoscopy.
Risk-adjusted Cusum analysis allows real-time monitoring
of proficiency levels and provides strict criteria for retrain-
ing. Institution-wide Cusum analysis adjusting for node size
accurately delineates time to proficiency, which at a large
academic center is approximately 22 cases. We encourage
further exploration of Cusum analysis as a widelydiovascular Surgery c Volume 146, Number 6 1391
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Sapplicable evaluative tool for trainees learning new surgical
techniques.
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FIGURE E1. Observed sensitivity of endobronchial ultrasound-guided
transbronchial needle aspiration on an institution level compared with an
expected sensitivity of 90%.
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